Lung Cancer Clinical Trial

Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS CLIA

Summary

The primary objective of this study is to substantiate prediction accuracy(with a tighter 95% confidence interval compared to current diagnostic modalities), of a lung cancer biomarker for risk stratification of patients into high and low risk categories to aid in clinical evaluation of the patient.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

The patient is being evaluated for the diagnosis of possible lung cancer or "rule out lung cancer" and is indicated for bronchoscopy.
The patient is undergoing bronchoscopy
≥ 21 years of age
Patient meets local site's standard of care (SOC) for performing diagnostic bronchoscopy
The patient is a current or former cigarette smoker (defined as having smoked >100 cigarettes in their lifetime.

Exclusion Criteria:

The Pulmonary physician does not recommend that bronchoscopy be performed
The patient is unable to be consented into the study or unable to comply with requirements of the study
The patient has previously been diagnosed with primary lung cancer
Immediately prior to bronchoscopy, the patient has been on a mechanical ventilator for ≥ 24 consecutive hours.

Study is for people with:

Lung Cancer

Estimated Enrollment:

756

Study ID:

NCT01309087

Recruitment Status:

Completed

Sponsor:

Allegro Diagnostics, Corp.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 13 Locations for this study

See Locations Near You

University of Alabama
Birmingham Alabama, 35294, United States
Georgia Lung Associates
Austell Georgia, 30106, United States
Indiana University
Indianapolis Indiana, 46202, United States
LSU
New Orleans Louisiana, 70112, United States
Beth Israel Deaconess Medical Center
Boston Massachusetts, 02215, United States
University of Missouri
Columbia Missouri, 65203, United States
New York University
New York New York, 10016, United States
Columbia University
New York New York, 10032, United States
University of Pennsylvania
Philadelphia Pennsylvania, 19104, United States
Temple University
Philadelphia Pennsylvania, 19140, United States
Vanderbilt University
Nashville Tennessee, 37232, United States
University of Virginia
Charlottesville Virginia, 22908, United States
University of British Columbia
Vancouver British Columbia, , Canada
Trinity College
Dublin , 8, Ireland

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

756

Study ID:

NCT01309087

Recruitment Status:

Completed

Sponsor:


Allegro Diagnostics, Corp.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider